10-K

Company

Werewolf Therapeutics, Inc.

Filed

March 7, 2024

Period of Report

December 31, 2023

Accession Number

0001785530-24-000012

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →